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Background: In vitro TGF- differentiates Th17 and
Tc17 cells, but TGF-RIIDN mice display multiorgan
autoimmune disorders.
Results: CD4T cells from TGF-RIIDN mice are resis-
tant to Th17 cell differentiation, whereas CD8T cells
acquire IL-17-producing phenotype, and IL-17 neutral-
ization or depletion inhibited inflammation in TGF-
RIIDN mice.
Conclusion: Tc17 cell differentiations in vivo are distinct
from Tc17 cell differentiations in vitro.
Significance: The Tc17 cell differentiation program is
unique to Th17.
TGF- is a pleiotropic cytokine that predominantly exerts
inhibitory functions in the immune system. Unexpectedly, the
in vitro differentiation of both Th17 and Tc17 cells requires
TGF-. However, animals that are impaired in TGF- signaling
(TGF-RIIDN mice) display multiorgan autoimmune disor-
ders. Here we show that CD4 T cells from TGF-RIIDN mice
are resistant to Th17 cell differentiation and, paradoxically, that
CD8 T cells from these animals spontaneously acquire an
IL-17-producing phenotype. Neutralization of IL-17 or deple-
tion of CD8 T cells dramatically inhibited inflammation in
TGF-RIIDN mice. Therefore, the absence of TGF- triggers
spontaneous differentiation of IL-17-producing CD8 T cells,
suggesting that the in vivo and in vitro conditions that promote
the differentiation of IL-17-producingCD8Tcells are distinct.
TGF- is a pleiotropic cytokine that influences nearly all cell
types (1). However, in the immune system, TGF- is widely
regarded as a regulatory cytokine (2–6). Thus, TGF- knock-
out mice exhibit hyper-lymphoproliferation and succumb to
multiorgan autoimmune disease (7). Similarly, mice expressing
a dominant negative TGF- receptor (TGF-RIIDN) exhibit
spontaneous differentiation of Th cells and display multiorgan
autoimmune inflammation, most notably inflammatory bowel
disease (IBD)4 (8).
Over the past several years, it has become widely accepted
that T helper 17 (Th17) cells play a pathogenic role in a large
number of autoimmune and inflammatory diseases (9, 10).
Interestingly, TGF- along with IL-6 are required for the dif-
ferentiation of this inflammatory Th cell subset (11, 12). It has
been shown that TGF-does not play a direct role in themolec-
ular orchestration of Th17 cell differentiation, but rather facil-
itates Th17 cell differentiation by inhibiting the differentiation
of Th1 and Th2 cells (13). In this context, it appears surprising
that transgenic animals carrying a dominant negative form of
the TGF- receptor II under control of the CD4 promoter
(CD4-TGF-RIIDN mice) exhibit multiorgan autoimmune
inflammation (14, 15). This led us to examine the role of IL-17
in autoimmune inflammation in TGF-RIIDN mice. Surpris-
ingly, we found that TGF-RIIDNmice produce large amounts
of IL-17 and IL-6 in the serum, suggesting spontaneous activa-
tion of IL-17-producing cells in vivo. Previously, it has been
shown that CD4T cells fromTGF-RIIDNmice fail to differ-
entiate into Th17 cells (16). Consistent with this finding, we
also found that CD4 T cells isolated from these mice were
resistant to Th17 cell differentiation. Instead we found that
CD8 T cells from these animals produced large amounts of
IL-17 along with other pro-inflammatory cytokines upon acti-
vation. Finally, we showed that neutralization of IL-17 with
anti-IL-17 antibodies or depletion of CD8 T cells with anti-
CD8 antibodies dramatically reduced inflammation in these
mice. Therefore, TGF- is not required for the in vivo differen-
tiation of IL-17-producing CD8 T (Tc17) cells but instead
inhibits the differentiation of this cell type. Taken together
these results indicate that the conditions that facilitate Tc17
cell differentiation in vivo are distinct from those that promote
Tc17 cell differentiation in vitro.
MATERIALS ANDMETHODS
Mice—C57BL/6 and TGF-RIIDN transgenic mice (a kind
gift by Prof. Ruslan Medzhitov, Yale University, New Haven,
CT) on a C57BL/6 background (6–8 weeks of age) were ini-
tially purchased from The Jackson Laboratory. Stat6/T-
bet/TGF-RIIDNmice were generated in our International
Centre for Genetic Engineering and Biotechnology (ICGEB)
knock-out facility by crossing Stat6/T-bet/ double knock-
outwithTGF-RIIDN.All animalswere subsequently bred and
maintained in the animal facility of the ICGEB, New Delhi,
India.
Reagents—Fluorochrome-conjugated antibodies against
IFN- (XMG1.2) and IL-17 (TC11-18H10) and unconjugated
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antibodies to CD3 (145.2C11), CD28 (37.51.1), CD4 (GK1.5),
and CD8 (TIB105) were purchased from BD Biosciences. Anti-
bodies to cytokines (IL-4, IL-6, IL-12, IFN-, and TGF-) were
purchased from R&D Systems. IL-17 (MM17F3)-neutralizing
antibodies were purchased from eBioscience.
Detection of Cytokines—Cytokine levels in serum and culture
supernatants were determined by multiplexed bead array
immunoassay using the Luminex technology (Bio-Plex; Bio-
Rad Laboratories).
Differentiation of Th Cell Subsets—Naive CD25CD62Lhi-
CD44lo CD4 T cells were sorted from lymph nodes by using the
FACSDiva software (BD Biosciences). These cells were differenti-
ated under Th1- or Th2-polarizing conditions. In brief, 106 CD4
lymphocytes/mlwere activatedwith 1g/ml anti-CD3 antibodies
bound to plastic and 2 g/ml soluble anti-CD28 antibodies. 10
ng/ml IL-12 and 10 g/ml anti-IL-4 antibodies were included in
Th1 cultures, whereas 5 ng/ml anti-IL-4 antibodies, anti-IL-12
antibodies, and anti-IFN- antibodies (each at 10 g/ml) were
supplied forTh2cultures.After24h, IL-2wasaddedtoall cultures.
Cells were divided at a 1:4 ratio after 3 days and allowed to rest
under the described cytokine culture conditions in the absence of
anti-CD3 and anti-CD28 antibodies for another 2 days. Differen-
tiation of Th17 cells was performed as described previously (11,
12). In brief, FACS-sorted naive CD4T cells were activated with
plate-bound anti-CD3 and anti-CD28 antibodies in the presence
of 5 ng/ml TGF-, 20 ng/ml IL-6, or both. Cultures were termi-
nated after different time points for analysis of mRNA expression
and cytokines produced in the supernatants. All cell cultures were
maintained in RPMI 1640 medium supplemented with 2 mM
L-glutamine, 50M2-mercaptoethanol, 10%heat-inactivatedFBS,
and 10mM gentamycin.
Isolation of CD8TCells from Splenocytes—For the isolation
of CD8 T cells from spleen, we prepared single cell suspen-
sions and then centrifuged the cells. Next, we lysed red blood
cells by red blood cell (RBC) lysis buffer and washed the cells
twice with RPMI-1640 supplemented with 10% FCS.We resus-
pended the cells in a minimal volume (50 l) of chilled 10%
RPMI 1640, added 30 l of magnetic-activated cell sorting
beads, and incubated for 45 min at 4 °C.
Flow Cytometric Analysis—Spleens were isolated frommice,
macerated by frosted slides in 10%RPMI 1640 (Invitrogen), and
made into a single cell suspension. RBCs were lysed with RBC
cell lysis buffer andwashedwith 10%RPMI 1640. The cells were
counted, and 1 106 cells were used for surface staining. Cells
were washed twice with PBS and stained with antibodies
directed against surface markers with fluorescently labeled
FIGURE 1. IL-17plays a critical role in intestinal inflammation in TGF-RIIDNmice.A, wild type or TGF-RIIDN animalswere bled at the indicated ages, and
inflammatory cytokinesweremeasuredbymultiplex assays. A representative experiment is shownof three independent experimentswith a total of 18animals
per group. B, animals were injected with anti-IL-17 antibodies or control Ig as described under “Materials and Methods.” Intestines were harvested, fixed in
paraformaldehyde, and sectioned on 5-m glass slides using cryo-sectioning. Sections were stained with H&E. Note that anti-IL-17 antibodies dramatically
abrogate inflammation in the intestine. A representative experiment is shown from 30 slides prepared from six animals. C, quantitation of IBD. IBD was
quantified from 30 slides of six animals in a blinded fashion. Scores presented are the mean of all individual scores. D, cytokines produced by CD4 T cells
derived fromwild type or TGF-RIIDNmice activated on plate-bound anti-CD3 and anti-CD28 antibodies. E, cytokines produced by Th cells that differentiated
from CD4 T cells from wild type or TGF-RIIDN animals and were subjected to Th1, Th2, and Th17 differentiation conditions.
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anti-cytokine antibodies. For intracellular cytokine staining,
cells were treated with 50 ng/ml phorbol myristate acetate and
750 ng/ml ionomycin with 10 g/ml brefeldin A (Sigma-
Aldrich) added during the last 6 h of culture. Cells were washed
twice with PBS and resuspended in a permeabilization buffer
(Cytofix/Cytoperm kit; BD Biosciences), stained with fluores-
cently conjugated antibodies, and washed again with PBS.
Fluorescence intensity of fluorochrome-labeled cells was
measured by flow cytometry (FACSCantoTM II, BD Biosci-
ences). FACSDiva was used for acquiring the cells, and final
data analysis was performed by FlowJo (Tree Star).
Antibody Treatment—For the depletion of CD8-expressing
cells, we injected mice intravenously (50 g/mouse/dose) with
anti-CD8 antibody twice per week.
Histology—For histology, pieces of intestine and pancreas
were washed thoroughly in PBS and fixed in periodate-lysine-
paraformaldehyde. Tissues were embedded in paraffin, and
5–6-m sections were cut. Sections were stained with hema-
toxylin and eosin (H&E) and examined microscopically.
Statistics Analysis—All data were derived from at least three
independent experiments. Statistical analyses were conducted
using the SPSS10 software, and values were presented as
mean  S.D. Significant differences between the groups were
determined by analysis of variance followed by Tukey’s multi-
ple comparison test (SPSS software). A value of p  0.05 was
accepted as an indication of statistical significance.
RESULTS ANDDISCUSSION
Previously, it was reported that CD4-TGF-RIIDN animals
exhibit multiorgan autoimmune inflammation and spontane-
ous differentiation ofTh1 andTh2 cells (14, 15). In recent years,
IL-17, an inflammatory cytokine predominantly produced by
Th17 cells, has been implicated in many autoimmune disor-
ders. Differentiation of Th17 cells requires TGF- (11, 12).
Thus, we determined production of IFN-, IL-4, and IL-17, as
the representative cytokines of Th1, Th2, and Th17 cells,
respectively, by Th cells from TGF-RIIDN mice. We found
that young animals had increased levels of the characteristic
Th1 and Th2 cytokines in their serum when compared with
wild type littermates (Fig. 1A), which is in agreement with our
previous study (13). However, the levels of these cytokines
gradually decreased as the animals aged (Fig. 1A). Surpris-
ingly, we observed that the levels of IL-17 in the serum grad-
ually increased (Fig. 1A) as the animals aged and started to
show evidence of intestinal inflammation. To investigate
whether the elevated IL-17 levels were responsible for the
observed inflammation in the intestine, we injected anti-
IL-17 antibodies into these animals twice a week starting at 4
weeks of age. Interestingly, we found that inhibition of IL-17
dramatically abrogated inflammation in the intestine (Fig. 1,
B and C). These observations suggested that IL-17 plays an
important role in the development of intestinal inflamma-
tion in TGF-RIIDN mice. However, it is important to note
that treatment with anti-IL-17 antibodies could not com-
pletely abrogate inflammation, which is consistent with
prior studies indicating that factors in addition to IL-17 con-
tribute to intestinal inflammation (17).
Next, we determined the source of IL-17 in TGF-RIIDN
animals at the onset of inflammation. We isolated CD4 T
FIGURE 2. CD8 T cells are the predominant source of IL-17 that induces intestinal inflammation in TGF-RIIDN mice, and unlike Th17 cells, in vivo
differentiation of Tc17 cells requires neither TGF- nor IL-4 or IFN-. A, cytokines produced by CD8 T cells derived fromwild type and TGF-RIIDNmice.
B, FACS analysis to show IL-17 production by CD8 T cells fromTGF-RIIDNmice.C, histological sections to show that anti-CD8 antibodies profoundly reduced
clinical scores of intestinal inflammation in TGF-RIIDN mice. The experiment shown is representative of three independent experiments (four mice in each
group).D, serumcytokines inC57BL/6 andStat6/T-bet/TGF-RIIDNmiceat the indicatedages. E, cytokines fromdifferentiatedCD4T cells fromC57BL/6,
TGF-RIIDN, and Stat6/T-bet/TGF-RIIDN mice. F, IL-17 production by CD8 T cells from TGF-RIIDN and Stat6/T-bet/TGF-RIIDN mice. The
experiment shown is representative of three independent experiments (six mice in each group).
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cells, activated these cells with plate-bound anti-CD3 plus
anti-CD28 antibodies, and determined the cytokines pro-
duced. We observed that these cells produced high amounts
of IL-4 and IFN-, but failed to produce IL-17 (Fig. 1D). We
further tested whether these cells could be differentiated
into polarized Th1, Th2, or Th17 cells under appropriate
culture conditions. Surprisingly, we found that for all culture
conditions tested, CD4 T cells derived from TGF-RIIDN
mice produced high amounts of IL-4 and IFN-, but IL-17
was not produced under any of these conditions (Fig. 1E).
Taken together, these observations suggested that CD4 T
cells are not the relevant cellular source of IL-17, which is
responsible for the observed intestinal inflammation in
TGF-RIIDN animals.
It has been well established that T cells are required for the
development of IBD (18) Because CD4 T cells were not the
pathogenic source of IL-17 in TGF-RIIDN animals, we tested
whether CD8 T cells from these animals produced IL-17. We
isolated CD8 T cells, activated these cells with plate-bound
anti-CD3 and -CD28 antibodies, and measured cytokine pro-
duction. We observed that CD8 T cells produced large
amounts of IL-17 as well as other pro-inflammatory cytokines
(Fig. 2, A and B). Therefore, these observations suggested that
CD8 T cells in these animals spontaneously differentiated to
an IL-17-producing phenotype. It is well known that IL-17 is
produced by T cells as well as several other innate cell types
(19). Therefore, to test whether CD8 T cells are the relevant
cellular source of IL-17, we treated TGF-RIIDN animals with
depleting anti-CD8 antibodies twice a week (50 g/mouse/
dose) starting at 4 weeks of age. We analyzed inflammation in
the gut at 12 weeks of age. We found that TGF-RIIDN mice
treated with anti-CD8 antibodies had profoundly reduced clin-
ical scores of intestinal inflammation when compared with
mice treated with isotype control antibodies (Fig. 2C). There-
fore, these observations suggested that CD8 T cells are the
predominant source of IL-17 that induces intestinal inflamma-
tion in TGF-RIIDN mice.
Previously, we have reported that TGF- is dispensable for
the molecular orchestration of Th17 cell differentiation but
instead inhibits Stat6 and T-bet induction, which facilitates
the differentiation of Th17 cells (13). Therefore, we tested
Tc17 differentiation in Stat6/T-bet/TGF-RIIDN ani-
mals. As shown in Fig. 2D, these animals produced very large
amounts of IL-17 in their serum. Next, we compared IL-17
production in CD4 T cells derived from TGF-RIIDN and
Stat6/T-bet/TGF-RIIDN mice (Fig. 2E). Consistent
with our findings above, CD4 T cells from TGF-RIIDN
animals were resistant to Th17 cell differentiation but pro-
duced high amounts of IL-4 and IFN- irrespective of the
differentiation condition used (Fig. 2E). In sharp contrast,
CD4 T cells derived from Stat6/T-bet/TGF-RIIDN
mice were unable to differentiate into IL-4- or IFN--pro-
ducing cells but readily differentiated into IL-17-producing
cells (Fig. 2E). Next, we tested IL-17 production by CD8 T
cells in these animals. We found that CD8 T cells from
TGF-RIIDN and Stat6/T-bet/TGF-RIIDN animals
produced similar amounts of IL-17 (Fig. 2F). Therefore,
unlike Th17 cells, in vivo differentiation of Tc17 cells
requires neither TGF- nor IL-4 or IFN-. Our previous
study indicated that TGF- does not play a direct role in
Th17 cell differentiation but rather facilitates Th17 cell dif-
ferentiation by inhibiting T-bet and Stat6 expression (13).
These findings are in agreement with prior studies showing
that production of IFN- in CD8 T cells is independent of
T-bet expression (20). However, these findings contrast with
prior in vitro studies, which provided evidence that culture
of naive CD8 T cells with TGF- and IL-6 facilitates the
differentiation of Tc17 cells (21).
In summary, our data establish that TGF- is not only dis-
pensable but in fact inhibitory to Tc17 cell differentiation in
vivo, which differs from the requirements for TGF- in the
differentiation of these cells in vitro. Unlike Th17 cells, differ-
entiation of Tc17 cells is not regulated by Stat6 or T-bet. There-
fore, the Tc17 differentiation program is unique.
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